Pancreatic Acinar Cell Carcinoma

general

An adenocarcinoma arising from the pancreas. It is characterized by the presence of relatively uniform malignant cells which form acinar patterns. It usually occurs during adulthood. Signs and symptoms include abdominal pain, weight loss, nausea, and diarrhea. It may metastasize to regional lymph nodes and the liver. A minority of patients develop lipase hypersecretion syndrome. This syndrome may be seen in patients with liver metastases and it is characterized by excessive secretion of li

67

Centers

144

Active Trials

Cancer Funding

Specific Cancer Types(1)

Top Centers for Pancreatic Acinar Cell Carcinoma(67)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
67.5
2
NCI Comprehensive
Active Research Program
67.5
3
NCI Comprehensive
Active Research Program
67.5
4
NCI Comprehensive
Active Research Program
67.5
5
NCI Comprehensive
Active Research Program
67.5
6
NCI Comprehensive
Active Research Program
67.5
7
NCI Comprehensive
Active Research Program
67.5
8
NCI Comprehensive
Active Research Program
67.5
9
NCI Clinical
Active Research Program
67.5
10
NCI Comprehensive
Active Research Program
67.5
11
Active Research Program
67.5
12
NCI Clinical
Active Research Program
67.5
13
NCI Comprehensive
Active Research Program
67.5
14
Active Research Program
67.5
15
Active Research Program
67.5
16
Active Research Program
67.5
17
Active Research Program
67.5
18
NCI Comprehensive
Active Research Program
57.8
19
NCI Comprehensive
Active Research Program
57.8
20
NCI Comprehensive
Active Research Program
57.8
21
NCI Comprehensive
Active Research Program
57.8
22
NCI Comprehensive
Active Research Program
57.8
23
NCI Comprehensive
Active Research Program
57.8
24
NCI Comprehensive
Active Research Program
57.8
25
NCI Clinical
Active Research Program
57.8
26
NCI Comprehensive
Active Research Program
57.8
27
Active Research Program
57.8
28
Active Research Program
57.8
29
Active Research Program
57.8
30
NCI Comprehensive
Active Research Program
42.4
31
NCI Comprehensive
Active Research Program
42.4
32
NCI Comprehensive
Active Research Program
42.4
33
NCI Comprehensive
Active Research Program
42.4
34
NCI Comprehensive
Active Research Program
42.4
35
NCI Comprehensive
Active Research Program
42.4
36
NCI Comprehensive
Active Research Program
42.4
37
NCI Comprehensive
Active Research Program
42.4
3842.4
39
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
42.4
40
NCI Comprehensive
Active Research Program
42.4
41
NCI Comprehensive
Active Research Program
42.4
42
NCI Comprehensive
Active Research Program
42.4
43
NCI Clinical
Active Research Program
42.4
44
NCI Comprehensive
Active Research Program
42.4
45
NCI Comprehensive
Active Research Program
42.4
46
NCI Comprehensive
Active Research Program
42.4
47
Active Research Program
42.4
48
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
42.4
49
NCI Comprehensive
Active Research Program
42.4
50
Active Research Program
42.4
51
NCI Comprehensive
Active Research Program
42.4
52
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
42.4
53
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
42.4
5442.4
55
Active Research Program
42.4
56
Active Research Program
42.4
57
NCI Basic_laboratory
Active Research Program
42.4
58
Active Research Program
42.4
5942.4
60
Active Research Program
42.4
61
Active Research Program
42.4
62
Active Research Program
42.4
63
Active Research Program
42.4
6429.6
65
NCI Comprehensive
29.6
66
NCI Comprehensive
29.6
6729.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →